Dr Alec Maynard

Dr Alec Maynard is a dedicated Consultant Medical Oncologist who specialises in the non-surgical management of solid tumours, with a particular focus on renal cancers and advanced immunotherapy applications. Working alongside multidisciplinary healthcare teams, he provides compassionate, evidence-based care tailored to the individual needs of each patient. His clinical practice encompasses the thorough assessment, diagnosis, and systemic treatment of complex malignancies, supporting individuals and their families through every stage of their care journey.

Dr Maynard completed his advanced specialist training in medical oncology and earned his Medical Oncology Specialty Certification (SCE) through the Royal College of Physicians in 2021. He maintains active professional membership with the Royal College of Physicians and contributes to collaborative national research as a member of the UK Renal Oncology Group. Through continuous professional development and academic collaboration, he remains committed to applying the latest evidence-based standards to routine clinical practice.

His clinical interests centre on systemic anti-cancer therapies, including modern immunotherapies, targeted therapies, and chemotherapy regimens. Dr Maynard is actively involved in clinical trial research, with specific interests in optimising treatment outcomes and managing immune-related adverse events associated with checkpoint inhibitor therapies. He prioritises clear, open communication, ensuring that patients feel fully informed, empowered, and reassured when making decisions about their treatment plans.